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Promise of Tomorrow
The topics discussed in this conference represent
great scientific opportunity that we will exploit in the
future. The objectives of the research programs at
NIEHShavebeentounderstandhowchemicalsinteract
with living material, cell metabolism, function, and
structure. If these mechanisms are understood, it is
easier to makejudgments aboutpotential health effects
and to suggest ways to ameliorate these effects. As
Manny Farber emphasized (1), "We must understand
the process."
This conference shows how the new biology dealing
with cell growth and differentiation, regulation (inter-
cellularcommunications, etc.)isbeingappliedtospecific
organ systems: CNS, reproduction and development,
genetictoxicology, andcarcinogenesis. Muchofthenew
biology is common to all cells and it is hoped that as we
achieve greater understanding, we will be able to un-
derstand the role of chemicals in the etiology of many
specific disease processes.
Although we are aware ofmany specific risk factors,
the etiology ofmost chronic diseases remains unknown.
Advances inbasicscience shouldpermitustodetermine
better the role that chemicals play in these common
diseases. Environmentalfactorshave someroleinmany
diseases, even thosecommonlythought ofagenetic dis-
ease. If you think about it, environment has a major
role in such straightforward genetic diseases as phen-
ylketonuria(PKU). ItisreallythesusceptibilitytoPKU
that is inherited; the disease is due to toxicity of the
excessive phenylalanine thatis notmetabolized. A child
whoishomozygousforPKU(thatis, onewhoisdeficient
in phenylalanine hydroxylase and thus unable to hy-
droxylate phenylalanine) is normal inutero because the
environment provided by the mother is a safe environ-
ment; afterbirth, thatchildstill hasthediseasebutonly
shows the mental retardation when exposed to an un-
controlled environment containing phenylalanine that
cannot be metabolized by the normal pathways. Ifit is
possible to remove phenylalanine from the diet (alter
the environment), the child is normal. This may be a
rather extreme view of the role ofenvironment in dis-
ease and not what is ordinarily though of, but I want
tomakethepointthatmostdiseaseis, indeed, theresult
of some interaction between the environment and the
constitution ofthe individual.
To carry the relationship between genetics and en-
vironment one step further to the realm of a common
quasi genetic/environmental disease, diabetes mellitus,
there are two types ofdiabetes, insulin-dependent and
noninsulin-dependent diabetes. For insulin-dependent
diabetes mellitus (IDDM), the defect is related to two
abnormal genes: one is the IDDM gene; the second is
one ofthe HLA family. Interestingly, in children with
both genes, only about one-third develop the IDDM
disease. Thus, the presence ofthe clinical disease prob-
ably is determined by an environmental factor.
And then there are a number of important chronic
diseases that truly have no known etiology, like ath-
erosclerosis. Manyenvironmentalfactorshavebeenim-
plicated in the pathogenesis ofthis disorderand itmay,
in fact, be multifactorial. The more we learn about the
cellular events that are altered in a disease, the more
likelywearetopinpointitsetiology. Forinstance, there
isincreasingevidencethatatheromatous plaques, ama-
jorcause ofarterial disease, maybebenigntumorsthat
can contain oncogenelike materials. The tumors are
monoclonal and presumably result from a carcinogen
insult. These benign tumors may be influenced by en-
vironmental factors such as cholesterol, perhaps a pro-
moter.
Cancer, of course, is probably the most frightening
disease in the present world (although AIDS may be
the most emotional at this particular point in time).
Nevertheless, there are several approaches being pur-
sued to treat [as elegantly presented by Dr. Waldmann
(2)] and to prevent or control cancer. One of our roles
is prevention: to study factors, particularly toxic chem-
icals in the environment, that may contribute to the
etiology of cancer. To date, one of our major contri-
butions continues to be to identify many chemicals hav-
ingcarcinogenicpotentialandtodevelopnewandbetter
research approaches on how this can be done.
Two major problems in linking a chemical to a par-
ticular cancer in a person have been, first, the long
latent period between exposure to acarcinogenic chem-
ical and the appearance ofclinical cancer; and, second,
that everyone is exposed to many carcinogens all the
time. However, as we have heard in this conference
today, newknowledge aboutthe carcinogenicprocesses
andtheroleofactivatedoncogenesmayprovideanother
tool we need to finally be able to link a carcinogen to
the tumor in humans. Norton Nelson (3) and other pre-
sented the concept of the continuum from exposure to
endpoint, i.e., exposure, dose, internal dose, preclinical
effect, and on to frank clinical disease. Another fasci-
nating aspect is the relation between oncogenes and
chemical effects on cells and signal transduction. Some
oncogenes regulate the production ofproteins that are
involved in cell communication, growth factors, and/or
kinases.122 D. P. RALL
A major group ofdisease touched on in these papers
(4) relates to effects of toxic chemicals on the nervous
system. For instance, Alzheimer's and related diseases
seem to be increasing in our aging population and are
ofgrowingimportance. Atpresentthere are some clues
linkingenvironmentalfactorswithAlzheimer's andPar-
kinson's diseases. If we can find ways of linking sub-
clinical neuronal damage to chemicals, using both lab-
oratory and epidemiologic methods, we may have some
basis for prevention in the future.
These are only a few examples selected to highlight
new areas of promise for future research. There are
other exciting techniques that must be considered. One
is the use ofmagnetic resonance in the study ofin vivo
cellandtissuemetabolismanditsapplicationinimaging.
Tumors 1 mm or less in diameter can be visualized in
living rats. Tomorrow's scientific advances can only be
achieved bytheestablished linksbetweenbasic science,
toxicology, and clinical medicine, and this meeting has
demonstrated the strength and vigor of these links.
Thisbodes wellforthefuture ofenvironmental health
research.
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